Cite
HARVARD Citation
Schett, G. et al. (2014). AB0746 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, and the Impact of Baseline Weight and BMI on ACR20 and HAQ-DI Response: Pooled Results from 3 Phase 3, Randomized, Controlled Trials. Annals of the rheumatic diseases. p. 1050. [Online].